Ashmarin I P, Pastorova V E, Liapina L A, Kudriashov B A, Kalikhevich V N, Kamenskiĭ A A, Azieva L D
Izv Akad Nauk SSSR Biol. 1991 Mar-Apr(2):302-6.
Taftsine tetrapeptide has antiprocoagulatory properties in vitro in the presence of plasma. Taftsine exerts depolymerization influence on fibrin monomer in concentrations of 10(-1) to 10(-9) mg/ml. At intravenous injection in doses of 1 mg and 300 ug/kg, taftsine causes the increase in plasma clotting time and significant increase in enzymatic and nonenzymatic fibrinolysis. The effect can be observed during 120 min after injection of the peptide.
塔夫辛四肽在有血浆存在的体外环境中具有抗凝作用。塔夫辛在浓度为10(-1)至10(-9)毫克/毫升时,对纤维蛋白单体发挥解聚作用。以1毫克和300微克/千克的剂量静脉注射时,塔夫辛会使血浆凝血时间延长,并显著增强酶促和非酶促纤维蛋白溶解作用。在注射该肽后的120分钟内都可观察到这种效果。